Stonepine Capital Management, LLC A Tyr Pharma Inc Transaction History

Stonepine Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.11 - $1.51 $4.6 Million - $6.26 Million	-4,144,366 Reduced 89.58%	482,258 $680 Million
Q3 2023 Nov 13, 2023	BUY	$1.55 - $2.23 $7.17 Million - $10.3 Million	4,626,624 New	4,626,624 $7.31 Billion
Q2 2023 Aug 11, 2023	SELL	$1.72 - $2.57 $341,416 - $510,139	-198,498 Reduced 4.11%	4,627,224 $9.99 Million
Q1 2023 May 12, 2023	BUY	$1.88 - $2.5 $9.07 Million - $12.1 Million	4,825,722 New	4,825,722 $10.1 Million
Q3 2022 Nov 10, 2022	SELL	$2.79 - $4.15 $1,674 - $2,490	-600 Reduced 0.1%	600,980 $1.8 Million
Q1 2022 May 16, 2022	BUY	$4.75 - $7.54 $361,232 - $573,409	76,049 Added 14.47%	601,580 $3.22 Million
Q4 2021 Feb 14, 2022	BUY	$7.29 - $9.5 $838,320 - $1.09 Million	114,996 Added 28.01%	525,531 $3.93 Million
Q3 2021 Nov 12, 2021	BUY	$4.22 - $12.48 $1.73 Million - $5.12 Million	410,535 New	410,535 $3.73 Million

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.